Retractable Technologies Interest Expense 2011-2026 | RVP

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Retractable Technologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	227 K	260 K	167 K	177 K	211 K	213 K	220 K	223 K	231 K	231 K	240 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
260 K	167 K	218 K

Quarterly Interest Expense Retractable Technologies

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	33.5 K	-	36.1 K	37.5 K	43.6 K	-	40.3 K	38.4 K	47.1 K	-	52.9 K	54.7 K	65.1 K	-	36.1 K	36 K	33.8 K	36 K	40.7 K	43.5 K	45.9 K	41 K	42 K	44 K	50 K	-	53 K	58 K	48.1 K	-	52 K	56.7 K	49.6 K	-	58.3 K	53.1 K	53.8 K	-	55.2 K	56 K	57.2 K	-	59.5 K	60.6 K	52.1 K	-	69 K	70.3 K	72.1 K	-	62.5 K	65.5 K	56.9 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
72.1 K	33.5 K	50.4 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
Baxter International BAX	408 M	$ 20.66	1.27 %	$ 10.5 B	USA
Becton, Dickinson and Company BDX	613 M	$ 205.09	1.16 %	$ 59 B	USA
Ekso Bionics Holdings EKSO	-1 K	$ 8.15	-7.6 %	$ 164 M	USA
Alcon ALC	192 M	$ 80.67	-0.38 %	$ 40.4 B	Schweiz
AtriCure ATRC	-326 K	$ 42.59	1.96 %	$ 2 B	USA
electroCore ECOR	6.3 M	$ 5.15	6.19 %	$ 28.4 K	USA
Haemonetics Corporation HAE	-9.75 M	$ 84.98	2.36 %	$ 4.28 B	USA
AngioDynamics ANGO	4.94 M	$ 10.02	-8.29 %	$ 409 M	USA
Harvard Bioscience HBIO	-227 K	$ 0.66	-1.92 %	$ 28 M	USA
The Cooper Companies COO	-16.4 M	$ 83.38	-0.63 %	$ 16.6 B	USA
ICU Medical ICUI	107 M	$ 152.88	1.7 %	$ 3.73 B	USA
Glaukos Corporation GKOS	13.6 M	$ 114.49	0.43 %	$ 5.55 B	USA
InfuSystem Holdings INFU	1.4 M	$ 8.9	-0.11 %	$ 184 M	USA
iRhythm Technologies IRTC	1.25 M	$ 188.16	0.41 %	$ 5.87 B	USA
Isoray ISR	2 K	-	0.03 %	$ 108 M	USA
Repro Med Systems KRMD	561 K	$ 5.79	3.02 %	$ 264 M	USA
LeMaitre Vascular LMAT	205 K	$ 85.05	1.55 %	$ 1.91 B	USA
Masimo Corporation MASI	300 K	$ 138.18	0.8 %	$ 7.36 B	USA
Merit Medical Systems MMSI	-711 K	$ 93.33	1.83 %	$ 5.43 B	USA
Microbot Medical MBOT	2 K	$ 2.19	3.55 %	$ 22.3 M	Israel
Nephros NEPH	2 K	$ 5.07	-1.74 %	$ 52.7 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.29	2.24 %	$ 23.1 M	USA
Envista Holdings Corporation NVST	-100 K	$ 23.52	2.53 %	$ 4.05 B	USA
OraSure Technologies OSUR	-380 K	$ 2.65	5.38 %	$ 197 M	USA
Pro-Dex PDEX	533 K	$ 41.83	4.47 %	$ 138 M	USA
Predictive Oncology POAI	3	$ 6.85	3.24 %	$ 37.4 M	USA
Pulse Biosciences PLSE	983 K	$ 14.71	-3.26 %	$ 707 M	USA
Repligen Corporation RGEN	8.12 M	$ 165.12	-2.32 %	$ 9.2 M	USA
ResMed RMD	3.2 M	$ 250.85	1.07 %	$ 36.6 B	USA
BioLife Solutions BLFS	497 K	$ 24.91	-1.97 %	$ 1.15 B	USA
STERIS plc STE	8.4 M	$ 260.64	0.52 %	$ 25.7 B	USA
Stereotaxis STXS	1.1 M	$ 2.57	-1.35 %	$ 207 M	USA
STAAR Surgical Company STAA	815 K	$ 22.43	1.08 %	$ 1.1 B	USA
Utah Medical Products UTMD	256 K	$ 58.5	1.39 %	$ 212 M	USA
Teleflex Incorporated TFX	57 M	$ 110.0	-13.07 %	$ 5.15 B	USA
West Pharmaceutical Services WST	-1 M	$ 274.0	-1.62 %	$ 20 B	USA
DENTSPLY SIRONA XRAY	12 M	$ 12.53	1.25 %	$ 2.55 B	USA